El Hospital Costa del Sol es un centro hospitalario gestionado por la Consejería de Salud de la Junta de Andalucía a través de la Agencia Sanitaria Costa del Sol, este siendo una empresa pública, ubicado a unos 7 km al este de la ciudad española de Marbella, junto a la autovía A-7.

During the past decade, H. Costa del Sol conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 2 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "H. Costa del Sol" #1 sponsor was "AO Innovation Translation Center" with 2 trials, followed by "Boehringer Ingelheim" with 2 trials sponsored, "PETHEMA Foundation" with 2 trials sponsored, "Adacyte Therapeutics SL" with 1 trials sponsored and "Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "H. Costa del Sol" #1 collaborator was "AO Foundation, AO Spine" with 1 trials as a collaborator, "Celgene" with 1 trials as a collaborator, "Janssen-Cilag Ltd." with 1 trials as a collaborator and "TFS Trial Form Support" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "H. Costa del Sol" are "Acute Lymphoblastic Leukemia" (1 trials), "Atherosclerotic Cardiovascular Disease" (1 trials), "Atrial Fibrillation" (1 trials), "Cardiovascular Diseases" (1 trials) and "Crohn Disease" (1 trials). Many other conditions were trialed in "H. Costa del Sol" in a lesser frequency.

Most popular intervention types in "H. Costa del Sol" are "Drug" (3 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Dexamethasone" (2 trials), "Adacolumn" (1 trials), "Cytosine arabinoside" (1 trials), "DOAC or VKA" (1 trials) and "Melphalan" (1 trials). Other intervention names were less common.

The vast majority of trials in "H. Costa del Sol" are 8 trials for "All" genders.

Currently, there are NaN active trials in "H. Costa del Sol". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in H. Costa del Sol, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in H. Costa del Sol, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".